Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

Chroman 1 di hydrochloride (CDIA-2014) Inquiry
Formula:
C24H30Cl2N4O4
Molecular Weight:
509.43

Plasma kallikrein-IN-4 (CDIA-2015) Inquiry
Formula:
C22H23N7O
CAS Number:
1357954-34-7
Molecular Weight:
401.46

Selachyl alcohol (CDIA-2016) Inquiry
Formula:
C21H42O3
CAS Number:
593-31-7
Molecular Weight:
342.56

Arbutamine hydrochloride (CDIA-2017) Inquiry
Formula:
C18H24ClNO4
CAS Number:
125251-66-3
Molecular Weight:
353.84

PCSK9-IN-11 (CDIA-2018) Inquiry
Formula:
C16H17ClFN5O3
Molecular Weight:
381.79

Tolvaptan-d7 (CDIA-2019) Inquiry
Formula:
C26H18D7ClN2O3
CAS Number:
1246818-18-7
Molecular Weight:
455.98

Olmesartan medoxomil-d6 (CDIA-2020) Inquiry
Formula:
C29H24D6N6O6
CAS Number:
1127298-67-2
Molecular Weight:
564.62

IOX2 sodium (CDIA-2021) Inquiry
Formula:
C19H15N2NaO5
CAS Number:
2377239-85-3
Molecular Weight:
374.32

Aprocitentan-d4 (CDIA-2022) Inquiry
Formula:
C16H10D4Br2N6O4S
Molecular Weight:
550.22

Tubulin inhibitor 31 (CDIA-2023) Inquiry
Formula:
C22H19NO2
Molecular Weight:
329.39

! For research use only. Not intended for any clinical use.